John M. Burke

Active 1976–2025

149
Papers
22,893
Citations
85
h-index
145
i10-index

Citations

Citations per year for John M. Burke1977: 4 citations1979: 5 citations1980: 1 citations1981: 3 citations1983: 4 citations1984: 10 citations1985: 14 citations1986: 14 citations1987: 8 citations1988: 14 citations1989: 23 citations1990: 19 citations1991: 16 citations1992: 18 citations1993: 36 citations1994: 32 citations1995: 48 citations1996: 15 citations1997: 39 citations1998: 59 citations1999: 43 citations2000: 55 citations2001: 68 citations2002: 40 citations2003: 74 citations2004: 76 citations2005: 99 citations2006: 87 citations2007: 99 citations2008: 104 citations2009: 133 citations2010: 166 citations2011: 150 citations2012: 152 citations2013: 199 citations2014: 186 citations2015: 180 citations2016: 162 citations2017: 151 citations2018: 161 citations2019: 456 citations2020: 450 citations2021: 500 citations2022: 482 citations2023: 421 citations2024: 669 citations2025: 324 citations2026: 5 citations1978: no citations, so this year is not shown1982: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,638 citing papers, 28.3% of this breakdownChina: 732 citing papers, 7.8% of this breakdownUnited Kingdom: 672 citing papers, 7.2% of this breakdownGermany: 528 citing papers, 5.7% of this breakdownCanada: 482 citing papers, 5.2% of this breakdownFrance: 456 citing papers, 4.9% of this breakdownItaly: 375 citing papers, 4% of this breakdownAustralia: 296 citing papers, 3.2% of this breakdownSpain: 266 citing papers, 2.8% of this breakdownSwitzerland: 231 citing papers, 2.5% of this breakdownNetherlands: 205 citing papers, 2.2% of this breakdownJapan: 192 citing papers, 2.1% of this breakdown
0%28.3%Other 24.1%

Fields

  • Biochemistry, Genetics and Molecular Biology44.7%
  • Medicine31.4%
  • Agricultural and Biological Sciences14.9%
  • Environmental Science1.5%
  • Immunology and Microbiology1.5%
  • Computer Science1.2%
  • Other4.8%

Topics

  • Genetic diversity and population structure4.7%
  • Lymphoma Diagnosis and Treatment3.6%
  • RNA and protein synthesis mechanisms2.8%
  • Genetic Mapping and Diversity in Plants and Animals2.7%
  • Genomics and Phylogenetic Studies2.7%
  • Chromosomal and Genetic Variations2.1%
  • Other81.4%

Coauthors

All papers

Open in search
  1. Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher R. Flowers, Gilles Salles - New England Journal of Medicine 2021 cited by 843

  2. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jaqueline Willemann-Rogerio, David I. Quinn, Thomas Powles - New England Journal of Medicine 2021 cited by 746

  3. Massive haplotypes underlie ecotypic differentiation in sunflowers

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 515

  4. Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph E. Burgents, Rodolfo F. Perini, Thomas Powles - New England Journal of Medicine 2024 cited by 285

  5. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Piotr Sawrycki, Naomi B. Haas, Howard Gurney, Mauricio Mahave, Naveed Sarwar, Antoine Thiery-Vuillemin, Marine Gross‐Goupil, Christine Chevreau, John M. Burke, Gurjyot K. Doshi, Bohuslav Melichar, Delphine Topart, Stéphane Oudard, Evgeniy Kopyltsov, H. Hammers, David I. Quinn, Ajjai Alva, Juliana de Menezes, Adriano Gonçalves e Silva, Eric Winquist, Alketa Hamzaj, Giuseppe Procopio, Boguslawa Karaszewska, Ewa M. Nowakowska-Zajdel, B. Yа. Alekseev, Rustem Gafanov, А. А. Измайлов, Andrey Semenov, S. G. Afanasyev, Oleg Lipatov, T.B. Powles, Sandy Srinivas, David F. McDermott, Samith T. Kochuparambil, Ian D. Davis, Katriina Peltola, Roberto Sabbatini, Jinsoo Chung, М. I. Shkolnik, В. Б. Матвеев, P. Gajate Borau, Steven McCune, Thomas E. Hutson, Alejandro Dri, Silvio Correia Sales, Carrie Yeung, Carmen Marcela Alcala Castro, Peter J. Boström, Brigitte Laguerre, Consuelo Buttigliero, Ugo De Giorgi, Eugeniy A. Fomin, Yousef Zakharia, Clara Hwang, Eric A. Singer, Jeffrey T. Yorio, David Waterhouse, Rubén Dario Kowalyszyn, Margarita Sonia Alfie, Eduardo Yañez Ruiz, Tomáš Büchler, Krista Kankaanranta, G. Ferretti, Go Kimura, Kazuo Nishimura, Naoya Masumori, Satoshi Tamada, Haruaki Kato, Hiroshi Kitamura, Iwona Danielewicz and 133 more - The Lancet Oncology 2022 cited by 278

  6. The sunflower genome provides insights into oil metabolism, flowering and Asterid evolution

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zhao Lai, Marie‐Christine Le Paslier, Yannick Lippi, Lolita Lorenzon, Jennifer R. Mandel, Gwenola Marage, Gwenaëlle Marchand, Elodie Marquand, Emmanuelle Bret-Mestries, Evan Morien, Savithri U. Nambeesan, Thuy Nguyen, Prune Pegot-Espagnet, Nicolas Pouilly, Frances Raftis, Erika Sallet, Thomas Schiex, Justine Thomas, Céline Vandecasteele, Didier Varès, Félicity Vear, Sonia Vautrin, Martín Crespi, Brigitte Mangin, John M. Burke, Jérôme Salse, Stéphane Muños, Patrick Vincourt, Loren H. Rieseberg, Nicolas Langlade - Nature 2017 cited by 848

  7. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis

    Authors: , , , , - Nature 2009 cited by 1,078

  8. Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2023 cited by 97

  9. Widespread natural variation of DNA methylation within angiosperms

    Authors: , , , , , , , , , , , , , , , - Genome biology 2016 cited by 589

  10. Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 424

  11. Sunflower pan-genome analysis shows that hybridization altered gene content and disease resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Plants 2018 cited by 301

  12. Stem Cell‐Derived Exosomes: A Potential Alternative Therapeutic Agent in Orthopaedics

    Authors: , , , , , - Stem Cells International 2016 cited by 111

  13. First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 307

  14. Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Haematology 2022 cited by 89

  15. Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 161

  16. Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study

    Authors: , , , , , , , , , , , , , , , , - Blood 2014 cited by 638

  17. A target enrichment method for gathering phylogenetic information from hundreds of loci: An example from the Compositae

    Authors: , , , , , , , , - Applications in Plant Sciences 2014 cited by 231

  18. Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL

    Authors: , , , , , , , , - Blood 2023 cited by 48

  19. Feeding the future

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steve Rounsley, Ruaraidh Sackville Hamilton, Ulrich Schurr, Nils Stein, ‍Norihiko Tomooka, Esther van der Knaap, David L. Van Tassel, J. Toll, José Francisco Montenegro Valls, Rajeev K. Varshney, J. A. Ward, Robbie Waugh, Peter Wenzl, Daniel Zamir - Nature 2013 cited by 566

  20. Massive haplotypes underlie ecotypic differentiation in sunflowers

    Authors: , , , , , , , , , , , , , , , , , , , - 2019 cited by 98

  21. Physicochemical modelling of cell signalling pathways

    Authors: , , , - Nature Cell Biology 2006 cited by 608

  22. Genomic islands of divergence are not affected by geography of speciation in sunflowers

    Authors: , , , , , , , , - Nature Communications 2013 cited by 318

  23. The genomics of linkage drag in inbred lines of sunflower

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 cited by 55

  24. Antibody–drug conjugates for previously treated aggressive lymphomas: focus on polatuzumab vedotin

    Authors: , , , , - Expert Review of Clinical Pharmacology 2020 cited by 21